Paper8552282
Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells.
Sperber BR and 3 others. Neurosci Lett, 1995. Cited by 181 papers, by iCite.
Cite this record
ConductScience Library. Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells. Papers, record 8552282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8552282
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcium-Calmodulin-Dependent Protein Kinases | Major topic |
| tau Proteins | Major topic |
| Alanine | |
| Amino Acid Sequence | |
| Animals | |
| CHO Cells | |
| Cricetinae | |
| Fluorescent Antibody Technique, Indirect | |
| Glycogen Synthase Kinase 3 | |
| Glycogen Synthase Kinases | |
| Humans | |
| Immunoblotting | |
| Molecular Sequence Data | |
| Mutation | |
| Phosphorylation | |
| Serine | |
| Transfection |
Source PubMed
Cited by71
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 181 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42395436 | Genetic Code Expansion, Enzymatic Modification, and C-Terminal Labeling Enable Facile Production of Highly Modified α-Synuclein. | bioRxiv | 2026 | https://conductscience.org/library/papers/42395436 | PubMed |
| 41353403 | Glycogen synthase kinase-3 activation and dysregulation of amyloid transport receptors expression and shedding in HIV-induced Alzheimer's disease-like pathology: modulatory effects of CCR5 antagonists. | Acta Neuropathol Commun | 2025 | https://conductscience.org/library/papers/41353403 | PubMed |
| 39900982 | Exploring novel and potent glycogen synthase kinase-3β inhibitors through systematic drug designing approach. | Sci Rep | 2025 | https://conductscience.org/library/papers/39900982 | PubMed |
| 39200352 | Insulin Resistance, a Risk Factor for Alzheimer's Disease: Pathological Mechanisms and a New Proposal for a Preventive Therapeutic Approach. | Biomedicines | 2024 | https://conductscience.org/library/papers/39200352 | PubMed |
| 37470970 | PKCα Isoform Inhibits Insulin Signaling and Aggravates Neuronal Insulin Resistance. | Mol Neurobiol | 2023 | https://conductscience.org/library/papers/37470970 | PubMed |
| 37449601 | Therapies for Tau-associated neurodegenerative disorders: targeting molecules, synapses, and cells. | Neural Regen Res | 2023 | https://conductscience.org/library/papers/37449601 | PubMed |
| 37264120 | Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer's disease? From preclinical studies to the clinical trials. | Mol Psychiatry | 2023 | https://conductscience.org/library/papers/37264120 | PubMed |
| 37091586 | Lowering levels of reelin in entorhinal cortex layer II-neurons results in lowered levels of intracellular amyloid-β. | Brain Commun | 2023 | https://conductscience.org/library/papers/37091586 | PubMed |
| 35922737 | Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling. | Inflammopharmacology | 2022 | https://conductscience.org/library/papers/35922737 | PubMed |
| 35723096 | Characterization of Early Alzheimer's Disease-Like Pathological Alterations in Non-Human Primates with Aging: A Pilot Study. | J Alzheimers Dis | 2022 | https://conductscience.org/library/papers/35723096 | PubMed |
| 35342350 | miR-200c suppression increases tau hyperphosphorylation by targeting 14-3-3γ in early stage of 5xFAD mouse model of Alzheimer's disease. | Int J Biol Sci | 2022 | https://conductscience.org/library/papers/35342350 | PubMed |
| 35325356 | The Role of Post-Translational Modifications on the Structure and Function of Tau Protein. | J Mol Neurosci | 2022 | https://conductscience.org/library/papers/35325356 | PubMed |
| 34122554 | The Potential of Induced Pluripotent Stem Cells to Treat and Model Alzheimer's Disease. | Stem Cells Int | 2021 | https://conductscience.org/library/papers/34122554 | PubMed |
| 33797746 | Long-term depression-related tau phosphorylation is enhanced by methylene blue in healthy rat hippocampus. | Pharmacol Rep | 2021 | https://conductscience.org/library/papers/33797746 | PubMed |
| 33782649 | Flavonoids as an Intervention for Alzheimer's Disease: Progress and Hurdles Towards Defining a Mechanism of Action. | Brain Plast | 2021 | https://conductscience.org/library/papers/33782649 | PubMed |
| 33197065 | GSK3α, not GSK3β, drives hippocampal NMDAR-dependent LTD via tau-mediated spine anchoring. | EMBO J | 2021 | https://conductscience.org/library/papers/33197065 | PubMed |
| 33117143 | Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease. | Front Aging Neurosci | 2020 | https://conductscience.org/library/papers/33117143 | PubMed |
| 32952546 | Circuitry and Synaptic Dysfunction in Alzheimer's Disease: A New Tau Hypothesis. | Neural Plast | 2020 | https://conductscience.org/library/papers/32952546 | PubMed |
| 32019113 | Genetic Dissection of Alzheimer's Disease Using Drosophila Models. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32019113 | PubMed |
| 29933579 | Autotaxin⁻Lysophosphatidic Acid Signaling in Alzheimer's Disease. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29933579 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GSK3B | 2932 | PubTator's text mining | https://conductscience.org/library/genes/2932 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8552282
GET https://conductscience.org/api/papers/v1/8552282/cited_by?page=2